Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	17.45B +7.9%
Revenue (ttm)	9.50B -17.8%
Net Income	891.15M -14.0%
EPS	0.77 -13.0%
Shares Out	1.13B
PE Ratio	20.01
Forward PE	13.60
Dividend	0.48 (3.00%)
Ex-Dividend Date	Apr 29, 2026

Volume	7,044,783
Open	16.20
Previous Close	15.85
Day's Range	15.31 - 16.20
52-Week Range	13.64 - 19.59
Beta	0.30
Analysts	Strong Buy
Price Target	20.07 (+29.48%)
Earnings Date	Aug 19, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 6,787
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.

Analyst Summary

According to 5 analysts, the average rating for 000739 stock is "Strong Buy." The 12-month stock price target is ¥20.07, which is an increase of 29.48% from the latest price.

Price Target

¥20.07

(29.48% upside)

Analyst Consensus: Strong Buy